These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 4167790)

  • 1. EEG studies in uraemic patients during extracorporeal haemodialysis or intermittent peritoneal dialysis.
    Zysno E; Reichenmiller HE; Dürr F
    Electroencephalogr Clin Neurophysiol; 1967 Oct; 23(4):384. PubMed ID: 4167790
    [No Abstract]   [Full Text] [Related]  

  • 2. [Longitudinal EEG study of uremic patients treated by extracorporeal hemodialysis and by intermittent peritoneal dialysis].
    Zysno E; Reichenmiller HE; Durr F
    Rev Neurol (Paris); 1967 Jul; 117(1):128-30. PubMed ID: 6063847
    [No Abstract]   [Full Text] [Related]  

  • 3. Electrophysiological studies on uremic patients-comparison of peritoneal dialysis and hemodialysis.
    Hughes JR; Roxe DM; del Greco F; Krumlovsky F; Ghantous W; Ivanovich P; Quintanilla A; Salkin M; Stone N; Reins M
    Clin Electroencephalogr; 1980 Apr; 11(2):73-82. PubMed ID: 7389152
    [No Abstract]   [Full Text] [Related]  

  • 4. Interleukin/cytokine profiles in haemodialysis and in continuous peritoneal dialysis.
    Jacobs P; Glorieux G; Vanholder R
    Nephrol Dial Transplant; 2004 Aug; 19 Suppl 5():V41-45. PubMed ID: 15284359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An integrated programme of haemodialysis and peritoneal dialysis: a single two-litre exchange per night plus haemodialysis every four to six days.
    Cambi V; Garini G; Occhialini L; Tagliavini D; Arisi L; David S
    Proc Eur Dial Transplant Assoc; 1983; 19():380-7. PubMed ID: 6878252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The EEG in uraemia.
    Zysno EA
    Electroencephalogr Clin Neurophysiol; 1970 Aug; 29(2):212-3. PubMed ID: 4194624
    [No Abstract]   [Full Text] [Related]  

  • 7. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis.
    Iglesias P; Díez JJ; Fernández-Reyes MJ; Méndez J; Bajo MA; Aguilera A; Selgas R
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):741-9. PubMed ID: 15163339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of L-arginine transport in undialysed chronic renal failure and continuous ambulatory peritoneal dialysis patients.
    Brunini TM; Roberts NB; Yaqoob MM; Ellory JC; Mann GE; Mendes Ribeiro AC
    Clin Exp Pharmacol Physiol; 2006; 33(1-2):114-8. PubMed ID: 16445709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sleep EEG and uraemia.
    Reichenmiller HE; Reinhard U; Dürr F
    Electroencephalogr Clin Neurophysiol; 1971 Mar; 30(3):263-4. PubMed ID: 4103206
    [No Abstract]   [Full Text] [Related]  

  • 10. Arterial blood pressure and effective peritoneal blood flow during intermittent peritoneal dialysis.
    Grzegorzewska A; Mariak I
    Pol J Pharmacol; 1996; 48(1):99-103. PubMed ID: 9112636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An analysis of the effectiveness and benefits of peritoneal dialysis and haemodialysis using Nigerian made PD fluids.
    Arogundade FA; Ishola DA; Sanusi AA; Akinsola A
    Afr J Med Med Sci; 2005 Sep; 34(3):227-33. PubMed ID: 16749353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in auditory P3 event-related potentials in uremic patients undergoing haemodialysis.
    Gallai V; Alberti A; Buoncristiani U; Firenze C; Mazzotta G
    Electromyogr Clin Neurophysiol; 1994; 34(7):397-402. PubMed ID: 7859667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemodialysis, continuous ambulatory peritoneal dialysis and cellular immunity.
    Collart F; Tielemans C; Dratwa M; Schandene L; Wybran J; Dupont E
    Proc Eur Dial Transplant Assoc; 1983; 20():190-4. PubMed ID: 6228939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma ghrelin levels in patients undergoing haemodialysis and peritoneal dialysis.
    Pérez-Fontán M; Cordido F; Rodríguez-Carmona A; Peteiro J; García-Naveiro R; García-Buela J
    Nephrol Dial Transplant; 2004 Aug; 19(8):2095-100. PubMed ID: 15187192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Densitometric and electrophysiological changes in uraemic encephalopathy.
    Di Paolo B; Delle Monache C; Di Paolo AM; Rossini PM; Cappelli P; Evangelista M; Albertazzi A
    Life Support Syst; 1983; 1 Suppl 1():151-3. PubMed ID: 6336398
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hemodynamic conditions in patients with uremia. Conventional hemodialysis treatment and alternative therapeutic methods].
    Lynggaard F; Pedersen T
    Ugeskr Laeger; 1984 Nov; 146(47):3642-9. PubMed ID: 6515996
    [No Abstract]   [Full Text] [Related]  

  • 17. The influence of larger molecules on cellular response in uremia.
    Giacchino F; Quarello F; Pozzato M; Giraudo G; Formica M; Quattrocchio G; Piccoli G
    Trans Am Soc Artif Intern Organs; 1983; 29():29-32. PubMed ID: 6608816
    [No Abstract]   [Full Text] [Related]  

  • 18. Neurophysiological abnormalities in uraemic encephalopathy.
    Albertazzi A; Di Paolo B; Del Rosso G; Gambi D; Rossini PM
    Proc Eur Dial Transplant Assoc; 1981; 18():652-7. PubMed ID: 7329993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular disease in haemodialysis and peritoneal dialysis: arguments pro peritoneal dialysis.
    Van Biesen W; Verbeke F; Vanholder R
    Nephrol Dial Transplant; 2007 Jan; 22(1):53-8. PubMed ID: 17050633
    [No Abstract]   [Full Text] [Related]  

  • 20. Kinetic studies of phagocytosis. II. The serum-independent uptake of IgG-coated particles by polymorphonuclear leukocytes from uremic patients on regular dialysis treatment.
    Hällgren R; Fjellström KE; Håkansson L; Venge P
    J Lab Clin Med; 1979 Aug; 94(2):277-84. PubMed ID: 458245
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.